Tariffs

News

The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.

News

Novartis has announced a massive investment in manufacturing and R&D facilities in the US so it can make "100% of its key medicines" there.

Market Access

At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.

News

Pharma leaders have told the EU that without reforms the bloc could lose out on major capital investment programmes and R&D spending.

News

European Commission President Ursula von der Leyen is scheduled to meet with EU pharma leaders today about how to respond to US tariffs.

News

Pharmaceuticals are exempt from the tariffs revealed by President Donald Trump, for now, but the industry is bracing for what may come next.